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Transient perfusion in human melanoma xenografts
I Tufto and EK Rofstad
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Summary Studies of transplantable rodent tumours have suggested that malignant tissue might experience
transient perfusion at the microvascular level. The purpose of the work reported here was to investigate
whether transient perfusion can be demonstrated in xenografted human tumours. Tumours of four melanoma
lines (A-07, D-12, R-18, U-25), grown orthotopically in Balb/c nu/nu mice, were included in the study.
Transient perfusion was studied by using the double-fluorescent staining technique. Hoechst 33342 and
DiOC7(3) were either administered simultaneously or Hoechst 33342 was administered 20 min before
DiOC7(3). Detection of transient perfusion by this method requires that vessels are non-functional for at least
5 min owing to the distribution half-lives of the dyes in the blood. Usable combinations of dye concentrations
were found by varying the concentrations of Hoechst 33342 and DiOC7(3) systematically. The level of
perfusion mismatch following simultaneous administration of the dyes ranged from approximately 1.5% for
U-25 tumours to approximately 3.0% for R-18 tumours at these combinations. Moreover, the fraction of
vessels stained only with Hoechst 33342 and the fraction of vessels stained only with DiOC7(3) were not
significantly different whether the dyes were administered simultaneously or sequentially. Transient perfusion
could not be demonstrated in any of the tumour lines. Thus, the fraction of vessels stained only with Hoechst
33342 and the fraction of vessels stained only with DiOC7(3) were not significantly higher after sequential than
after simultaneous administration of the dyes. Moreover, the vessels stained only with Hoechst 33342 and the
vessels stained only with DiOC7(3) were randomly distributed within the tumours whether the dyes were
administered simultaneously or sequentially. Consequently, acute hypoxia caused by transient perfusion is
probably a less pronounced phenomenon in malignant tissue than previous studies of rodent tumours have
suggested.
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Studies of the vasculature of rodent tumours implanted in
transparent chambers have suggested that malignant tissue
might experience transient perfusion at the microvascular
level, i.e. consecutive periods of non-perfusion and perfusion
occurring in individual vessels or small groups of neighbour-
ing vessels (Intaglietta et al., 1977; Reinhold et al., 1977).
Recent studies of three-dimensional tumours transplanted
subcutaneously or intramuscularly in mice and rats have
given resultsr supporting this suggestion. Several methods
were used to demonstrate transient perfusion in these
tumours, including laser Doppler flowmetry (Vaupel et al.,
1988), sequential injection of fluorescent dye and micro-
spheres (Chaplin et al., 1987), injection of fluorescent dye
followed by fluorescence-activated cell sorting (Young and
Hill, 1989; Minchinton et al., 1990) and sequential injection
of two fluorescent dyes having different excitation and emis-
sion properties (Trotter et al., 1989a, 1991).
The demonstration of transient perfusion in rodent
tumours led to the suggestion that tumours might show
regions of acutely hypoxic cells (Brown, 1979; Sutherland
and Franko, 1980), in addition to regions of chronically
hypoxic cells (Thomlinson and Gray, 1955). Acute hypoxia
might promote tumour progression and cause tumour treat-
ment resistance (Hill, 1990). Thus, tumour cells subjected to
acute hypoxia followed by reoxygenation show increased
metastatic potential (Young et al., 1988) and increased resis-
tance to some chemotherapeutic agents (Luk et al., 1990;
Sanna and Rofstad, 1994). Moreover, acutely hypoxic cells
are more resistant to radiation treatment than chronically
hypoxic cells (Sutherland and Durand, 1976; Yamaura and
Matsuzawa, 1979).
Different treatment strategies are required to overcome
radiation resistance caused by acutely and chronically
hypoxic tumour cells. The fraction of chronically hypoxic
cells might be reduced by the use of agents which increase the
diffusion distance of oxygen, whereas a reduced fraction of
acutely hypoxic cells might be achieved by the use of agents
which inhibit transient perfusion (Chaplin et al., 1991, 1993).
Nicotinamide has been shown to inhibit transient perfusion
and to reduce the fraction of acutely hypoxic cells in trans-
plantable murine tumours (Chaplin et al., 1990a; Horsman et
al., 1994). Clinical investigations of the potential usefulness
of nicotinamide in the radiation therapy of human cancer
have therefore been initiated (Zackrisson et al., 1994).
There is no clear evidence, however, that human tumours
show transient perfusion and hence have acutely hypoxic
cells. Acute hypoxia as a consequence of transient perfusion
has so far been demonstrated only in transplantable rodent
tumours. Reliable methods for demonstration of transient
perfusion in human tumours are not available. Studies of
transient perfusion in experimental human tumour models
are therefore urgently needed. The purpose of the work
reported here was to investigate whether human melanoma
xenografts show transient perfusion. Tumours of four differ-
ent lines, grown orthotopically in athymic mice, were




Adult Balb/c nu/nu mice, bred at our research institute, were
used as host animals for xenografted tumours. The mice were
maintained under specific pathogen-free conditions at con-
stant temperature (24-26°C) and humidity (30-50%). Steril-
ised food and tap water were given ad libitum. Four human
melanoma lines (A-07, D-12, R-18, U-25) were included in
the study (Rofstad, 1994). Xenografted tumours were initi-
ated from exponentially growing monolayer cultures in pas-
sages 75-100. Monolayer cells, cultured in RPMI-1640
medium (25 mM Hepes and L-glutamine) supplemented with
13% fetal calf serum, 250mg 1-' penicillin and 50 mg l-'
streptomycin, were detached by trypsinisation (treatment
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0.05% trypsin/0.02% EDTA solution at 37°C for 2 min).
Approximately 3.5 x I05 cells in 10gsl of Ca2l- and Mg2"-
free Hanks' balanced salt solution were inoculated intrader-
mally in the flanks of the mice by using a 100jsl Hamilton
syringe (Rofstad, 1994). Tumours with wet weights ranging
from 200 to 500 mg were subjected to investigation.
Fluorescent dyes and anaesthetics
The fluorescent dyes Hoechst 33342 (Calbiochem, La Jolla,
CA, USA) and DiOC7(3) (Molecular Probes, Eugene, OR,
USA) were dissolved in phosphate-buffered saline and 75%
dimethylsulphoxide, respectively, and administered intra-
venously in volumes of 50fsl. The anaesthetics ketamine
(Parke Davis, Barcelona, Spain) and azaperone (Janssen
Pharmaceutika, Beerse, Belgium) were diluted in physio-
logical saline and administered intramuscularly in doses of
33 mg kg-' body weight and 25 mgkg-' body weight respec-
tively.
Double-fluorescent staining technique
Transient perfusion was studied by using the double-fluo-
rescent staining technique, based on sequential administra-
tion of Hoechst 33342 and DiOC7(3) (Trotter et al., 1989a,
1991). Hoechst 33342 and DiOC7(3) have short distribution
half-lives in blood and provide selective staining of tumour
cells adjacent to functional vessels (Trotter et al., 1989b,
1990). The excitation and emission spectra differ between the
dyes, allowing separate detection by fluorescence microscopy
(Trotter et al., 1989a). Hoechst 33342 was injected 20min
before DiOC7(3) to avoid possible artifacts due to the long-
lasting vasoactive effect of DiOC7(3) (Trotter et al., 1989b).
Vessels stained only with Hoechst 33342 were considered to
be functional during the Hoechst 33342 injection and non-
functional during the DiOC7(3) injection, i.e. the vessels had
closed during the 20 miss interval between the two injections.
Similarly, vessels stained only with DiOC7(3) were considered
to be non-functional during the Hoechst 33342 injection and
functional during the DiOC7(3) injection, i.e. the vessels had
opened during the 20 min interval between the two injections.
A vessel had to be non-functional for at least 5 min to be
stained only with one of the dyes since both dyes are present
in the blood and can stain vessels for approximately 5 min
after the administration (Trotter et al., 1989a). Hoechst
33342 and DiOC7(3) were administered simultaneously in
control experiments. The mice were kept under anaesthesia
during the experiments. Anaesthesia has no significant
influence on the level of transient perfusion in rodent
tumours (Trotter et al., 1989a). The mice were killed by
cervical dislocation 5 min after the administration of
DiOC7(3). The tumours were excised, frozen in liquid nit-
rogen and stored at -80°C. Frozen sections, 5ytm thick,
were prepared and examined by fluorescence microscopy at a
magnification of x 250. A 100 W mercury lamp was used as
light source. Hoechst 33342 staining was visualised by using
a 340-380 nm band-pass exciting filter, a 400nm dichroic
mirror and a 430 nm long-pass suppression filter. DiOC7(3)
staining was visualised by using a 450-490 nm band-pass
exciting filter, a 510 nm dichroic mirror and a 515 nm long-
pass suppression filter. The total number of vessels examined
per tumour was 600. Six randomly selected regions of 100
vessels each were analysed separately. The fraction of vessels
stained only with Hoechst 33342 and the fraction of vessels
stained only with DiOC7(3) were determined. The sum of
these two values, i.e. the fraction of vessels stained only with
one of the dyes, was termed the level of perfusion mismatch.
The fractions of tumour regions in which the fraction of
vessels stained only with Hoechst 33342 minus the fraction of
vessels stained only with DiOC7(3) or the fraction of vessels
stained only with DiOC7(3) minus the fraction of vessels
stained only with Hoechst 33342 was high () 5%),
intermediate (>1% but <5%) or low (< 1%) were
recorded.
Statistical analysis
Statistical comparisons of data were performed by non-
parametric analysis using the Mann-Whitney U-test. A
significance criterion of P<0.05 was used.
Results
The concentrations of Hoechst 33342 and DiOC7(3) were
varied systematically to find combinations which were usable
for studies of transient perfusion. A combination was con-
sidered to be usable only if (a) the level of perfusion mis-
match was low after simultaneous administration and (b) the
fraction of vessels stained only with Hoechst 33342 and the
fraction of vessels stained only with DiOC7(3) were similar,
whether simultaneous or sequential administration was per-
.formed. The results from the experiments with R-18 tumours
are illustrated in Figure 1. The fraction of vessels stained
only with Hoechst 33342 was significantly higher than the
fraction of vessels stained only with DiOC7(3) for 15 mgkg-'
Hoechst 33342 and 1.0 mgkg' DiOC7(3) (P<0.05), 15 mg
kg-' Hoechst 33342 and 1.3 mgkg-' DiOC7(3) (P<0.05)































Figure 1 Fraction of vessels stained only with Hoechst 33342
(LEii) and fraction of vessels stained only with DiOC7(3) ( )
in R-18 tumours. (a) Simultaneous administration of Hoechst
33342 and DiOC7(3). (b) Sequential administration of Hoechst
33342 and DiOC7(3). The combinations of dye concentrations
were: 1, 15 mg kg-' Hoechst 33342 and 1.0 mgkg-' DiOC7(3); 2,
15mg kg-' Hoechst 33342 and 1.3mgkg-' DiOC7(3); 3,
12mgkg-' Hoechst 33342 and 1.0mgkg-' DiOC7(3); 4,
12mgkg-' Hoechst 33342 and 1.3mgkg-' DiOC7(3). Column-
s = mean values. Bars = SE of at least four tumours.
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Figure 2 Fraction of vessels stained only with Hoechst 33342 (L ) and fraction of vessels stained only with DiOC7(3) ( )
following simultaneous (sim) and sequential (seq) administration of the dyes. (a) A-07 tumours, 12mgkg' Hoechst 33342 and
1.0mgkg-' DiOC(3). (b) D-12 tumours, 15mgkg-' Hoechst 33342 and 1.3mgkg-' DiOC7(3). (c) R-18 tumours, 12mgkg-'
Hoechst 33342 and 1.3 mgkg-' DiOC7(3). (d) U-25 tumours 15mgkg-' Hoechst 33342 and 1.3 mgkg-' DiOC7(3). Columns
= mean values. Bars = SE of at least four tumours.
(P<0.05), after both simultaneous (Figure la) and sequential
(Figure 1b) administration. In contrast, the fraction ofvessels
stained only with Hoechst 33342 was not significantly
different from the fraction of vessels stained only with
DiOC7(3) for 12 mg kg-' Hoechst 33342 and 1.3 mgkg-'
DiOC7(3) (P>0.05), whether the administration was per-
formed simultaneously (Figure la) or sequentially (Figure
lb). Moreover, the level of perfusion mismatch following
simultaneous administration was low for this combination,
approximately 3.0% (Figure la). Consequently, the combina-
tion of 12mg kg-' Hoechst 33342 and 1.3 mg kg-' of
DiOC7(3) was considered to be usable for studies of transient
perfusion in R-18 tumours. Similar experiments were per-
formed with tumours of the other three lines. Usable com-
binations of dye concentrations, fulfilling the requirements
stated above, were found for all tumour lines. The combina-
tions were different for different lines: 12mgkg-' Hoechst
33342 and 1.0mgkg-' DiOC7(3) for A-07 tumours, 12mg
kg-' Hoechst 33342 and 1.3 mgkg-' DiOC7(3) for R-18
tumours and 15 mgkg-' Hoechst 33342 and 1.3 mg kg-'
DiOC7(3) for D-12 and U-25 tumours.
The results from the experiments in which these combina-
tions of dye concentrations were used, are illustrated in
Figure 2. The histograms show that the experimental condi-
tions required for reliable studies of transient perfusion were
met. Thus, the fraction of vessels stained only with Hoechst
33342 was not significantly different from the fraction of
vessels stained only with DiOC7(3) (P>0.05 for all lines,
both for simultaneous and sequential administration). More-
over, the level of perfusion mismatch following simultaneous
and sequential administration). Moreover, the level of per-
fusion mismatch following simultaneous administration was
sufficiently low to be acceptable; it ranged from approx-
imately 1.5% for U-25 tumours to approximately 3.0% for
R-18 tumours. Transient perfusion could not be demon-
strated in any of the tumour lines. Thus, the fraction of
vessels stained only with Hoechst 33342 and the fraction of
vessels stained only with DiOC7(3) were not significantly
higher after sequential than after simultaneous administra-
tion [P>0.05 for all lines for both Hoechst 33342 and
DiOC7(3)].
Evidence of transient perfusion was not found by analys-
ing the spatial distribution of vessels stained with only one of
the dyes either. Thus, the fractions of tumour regions in
which the fraction ofvessels stained only with Hoechst 33342
minus the fraction of vessels stained only with DiOC7(3) or
the fraction of vessels stained only with DiOC7(3) minus the
fraction of vessels stained only with Hoechst 33342 was high,
intermediate or low, respectively, were not significantly
different after simultaneous and sequential administration in
any of the tumour lines (P>0.05), i.e. the vessels stained
only with one of the dyes were randomly distributed within
the tumours whether the dyes were administered simul-
taneously or sequentially. Typical data are presented in
Figure 3, using two R-18 tumours as an example. The frac-
tion of vessels stained only with Hoechst 33342 and the
fraction of vessels stained only with DiOC7(3) are presented
for each of the six regions analysed in each tumour. The level
of perfusion mismatch in these regions ranged from 1% to
7% following simultaneous administration (Figure 3a) and
from 1% to 4% following sequential administration (Figure
3b).TransientpWfion
























Figure 3 Fraction of vessels stained only with Hoechst 33342
( ) and fraction of vessels stained only with DiOC7(3) ( )
in six regions (1-6) in R-18 tumours following administration of
12mg kg-' Hoechst 33342 and 1.3mg kg-' DiOC7(3). (a) Simul-
taneous administration of Hoechst 33342 and DiOC7(3). (b)
Sequential administration of Hoechst 33342 and DiOC7(3). Col-
umns = single tumour regions having 100 vessels each.
Discussion
Studies of transient perfusion in experimental tumours based
on sequential administration of Hoechst 33342 and DiOC7(3)
require documentation of the validity of the method to be
reliable (Trotter et al., 1990). The validity of the method
depends on an adequate choice of dye concentrations since
both dyes show dose-dependent vasoactive effects (Trotter et
al., 1989b, 1990). Usable combinations of dye concentrations
were found for the four tumour lines studied here by varying
the concentrations of Hoechst 33342 and DiOC7(3) systema-
tically. The level of perfusion mismatch following simultan-
eous administration of the dyes ranged from approximately
1.5% to approximately 3.0% at these combinations. More-
over, the fraction of vessels stained only with Hoechst 33342
and the fraction of vessels stained only with DiOC7(3) were
not significantly different whether the dyes were administered
simultaneously or sequentially. The possibility of erroneous
detection of transient perfusion owing to the use of inade-
quate dye concentrations was thus minimised, a significant
condition distinguishing the present study from previous
studies of rodent tumours.
The combinations of dye concentrations that were found
to be usable for studies of transient perfusion were different
for different tumour lines. The concentrations of Hoechst
33342 and DiOC7(3) have to be sufficiently high that tumour
cells adjacent to all functional vessels are stained, but not so
high that transient perfusion is detected erroneously owing to
the dose-dependent vasoactive effects of the dyes. At least
two conditions can cause the usable range of dye concentra-
tions to differ between tumour models. First, the rate at
which the dyes are taken up by perivascular tumour cells
might depend on the rate of tumour blood flow, causing the
minimum usable concentrations to be tumour line dependent.
Second, the magnitude and the duration of the vasoactive
effects of the dyes might depend on the architecture of the
vascular network, causing the maximum usable concentra-
tions to differ between tumour lines.
None of the human melanoma xenograft lines showed
significant evidence of transient perfusion. Thus, the fraction
of vessels stained only with Hoechst 33342 and the fraction
of vessels stained only with DiOC7(3) were not significantly
higher after sequential than after simultaneous administra-
tion of the dyes. Moreover, the vessels stained only with
Hoechst 33342 and the vessels stained only with DiOC7(3)
were randomly distributed within the tumours whether the
dyes were administered simultaneously or sequentially. The
number of tumours included in the study and the number of
vessels examined per tumour were sufficiently large that a
true difference of approximately 2% in level of perfusion
mismatch between sequential and simultaneous dye adminis-
tration would have been detected with a probability of 95%
for each tumour line. The probability of failing to detect a
true difference of approximately 2% in all four tumour lines
was thus insignificant.
It should be noticed, however, that detection of transient
perfusion by the method used here requires that vessels are
non-functional for at least 5 min because of the distribution
half-lives of the dyes in the blood (Trotter et al., 1989a).
Vessels receiving only plasma flow are not scored as non-
functional since the method relies on plasma-borne dyes. The
possibility that some tumour cells in our melanoma xenograft
lines might experience periods of acute hypoxia cannot there-
fore be excluded. Acute hypoxia might occur as a conse-
quence of fluctuations in the rate of blood flow in con-
tinuously functional vessels as well as local cessations of the
blood flow for periods shorter than 5 min.
The present data on human melanoma xenografts differ
from those published previously on rodent tumours. The
most extensive studies of transient perfusion making use of
the double-fluorescent staining technique have been perform-
ed in 50-1000 mg SCCVII tumours implanted subcutaneous-
ly over the sacral region of the mouse and in 200 mm3 C3H
tumours inoculated into the foot of the right hind limb of the
mouse. The levels ofperfusion mismatch were reported to be
7-11% (sequential administration) and 1-2% (simultaneous
administration) for SCCVII tumours (Trotter et al., 1989a,
1991; Chaplin et al., 1990a, b) and 7-9% (sequential admin-
istration) and 3-4% (simultaneous administration) for C3H
tumours (Horsman et al., 1990, 1994).
The extent of transient perfusion and acute hypoxia in
rodent tumours has been shown to depend on the tumour
model system, i.e. it differs with tumour line, implantation
site and tumour size. Thus, transient perfusion was found to
be a more pronounced phenomenon in SCCVII tumours
than in C3H tumours (Trotter et al., 1989a; Chaplin et al.,
1990a; Horsman et al., 1990, 1994). Acute hypoxia was dem-
onstrated to be the dominant form of hypoxia in subcut-
aneous but not in intramuscular KHT tumours (Siemann and
Keng, 1988; Minchinton et al., 1990) and SCCVII tumours
showed higher levels of perfusion mismatch when implanted
subcutaneously than when implanted intramuscularly (Trot-
ter et al., 1989a). The extent of transient perfusion in
SCCVII tumours was found to decrease with decreasing
tumour size (Chaplin et al., 1986; Trotter et al., 1991);
tumours weighing less than 100 mg did not show significant
transient perfusion (Trotter et al., 1989a).
The discrepancy between our data on human melanoma
xenografts and those reported by others on rodent tumours is
probably due to biological differences between the tumour
model systems. The differences are most likely attributable to
the tumours rather than to the host animals since SCCVIITransientperfusion
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tumours show the same level of perfusion mismatch when
implanted in syngeneic hosts and athymic mice (Chaplin and
Trotter, 1991). The xenografted human tumours were in
contrast to the rodent tumours grown in orthotopic sites in
the mouse. Orthotopic growth (growth in the dermal-epi-
dermal junction of the skin in the case of malignant mela-
noma) was achieved by intradermal inoculation of tumour
cells; intradermal inoculation results in tumours that infiltrate
the epidermis ofthe mice within a short time (Rofstad, 1994).
Inoculation in orthotopic sites seems to be important for
xenografted tumours to retain the biological characteristics of
the donor patients' tumours (Cornil et al., 1989; Fidler,
1991). Several essential biological properties of the donor
patients' tumours have been shown to be retained in our
orthotopic human tumour model systems, including vascular
and pathophysiological parameters (Rofstad, 1994). Conse-
quently, the xenografted tumours studied here are probably
more relevant models of human cancer than the rodent
tumour models used in previous studies of transient per-
fusion.
In conclusion, transient perfusion could not be demon-
strated in human melanoma xenografts grown orthotopically
in athymic mice by using the double-fluorescent staining
technique. This observation suggests that acute hypoxia as a
consequence of transient perfusion might be a less extensive
clinical problem than studies of transplantable rodent
tumours have indicated. A method for monitoring of blood
flow in individual vessels in human tumours is highly war-
ranted.
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